MetLife Investment Management’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,105
Closed -$85.6K 2984
2023
Q2
$85.6K Buy
+9,105
New +$85.6K ﹤0.01% 2774